CLASS II ONGOING Device recall · Reported 7 Dec 2022 · FDA Enforcement Report

Accelerate PhenoTest BC kit recalled by Accelerate Diagnostics

Accelerate Diagnostics is recalling Accelerate PhenoTest BC kit, distributed in 31 states. The recall was initiated on 17 Oct 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPart Number: 10101018 UDI-DI Code: 00862011000307 Lot Numbers: 5549A 5566A 5588A 5606A 5612A
Quantity recalled200 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0345-2023
FDA event ID
91075
Recalling firm
Accelerate Diagnostics, Tucson, AZ
Classification
Class II
Status
Ongoing
Recall initiated
17 Oct 2022
FDA classified
30 Nov 2022
Reported
7 Dec 2022
Type
Voluntary: Firm initiated
Customers notified by
Other
Reason category
Other Reasons

Timeline

17 Oct 2022Recall initiated by company
30 Nov 2022Classified by FDA+44 days
7 Dec 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and Streptococcus spp.

Product as listed by the FDA

Accelerate PhenoTest BC kit REF 10101018

Where it was distributed

U.S.: AR, CA, DC, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MN, MO, MS, MT, NC, ND, NJ, NY, OH, PA, RI, SC, TN, TX, VA, WA, and WV. O.U.S.: Germany, Italy, Kuwait, Latvia, Poland, Portugal, Romania, Saudi Arabia, Spain, and United Arab Emirates

ArkansasCaliforniaDistrict of ColumbiaFloridaGeorgiaIowaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaineMinnesotaMissouriMississippiMontanaNorth CarolinaNorth Dakota

Questions about this recall

Is Accelerate PhenoTest BC kit recalled?

Yes. Accelerate Diagnostics recalled Accelerate PhenoTest BC kit on 17 Oct 2022. The recall is Class II and its status is Ongoing. Recall number Z-0345-2023.

Why was it recalled?

Due improperly formulated and released bulk lot of fluorescence in situ hybridization (FISH) probes resulting in false positive identification results for Staphylococcus aureus and Streptococcus spp.

Which lots are affected?

Part Number: 10101018 UDI-DI Code: 00862011000307 Lot Numbers: 5549A 5566A 5588A 5606A 5612A

Where was it sold?

U.S.: AR, CA, DC, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MN, MO, MS, MT, NC, ND, NJ, NY, OH, PA, RI, SC, TN, TX, VA, WA, and WV. O.U.S.: Germany, Italy, Kuwait, Latvia, Poland, Portugal, Romania, Saudi Arabia, Spain, and United Arab Emirates

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Accelerate Diagnostics

All 4

Other Other Medical Devices recalls

All 13,778